<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Matrix metalloproteinases (MMPs), a family of extracellular soluble or membrane bound endopeptidases, are implicated in many physiological and pathophysiological functions-based on their capability to cleave <z:hpo ids='HP_0000001'>all</z:hpo> protein components of the extracellular matrix </plain></SENT>
<SENT sid="1" pm="."><plain>Recent studies have implicated several forms of MMPs in <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> like <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD), vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD), and <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of the present study was to analyse eight MMPs (MMP-1, -2, -3, -7, -8, -9, -10, -13) in the human cerebrospinal fluid (CSF) and to correlate with the well established biomarkers beta-amyloid(1-42) (Abeta), total-tau and phospho-tau-181 </plain></SENT>
<SENT sid="3" pm="."><plain>Our data show a significant decrease of MMP-2 and MMP-3 levels in the CSF in samples with significantly reduced Abeta levels </plain></SENT>
<SENT sid="4" pm="."><plain>It is concluded that MMP-2 and MMP-3 are directly linked to Abeta in the brain and a dysfunction may influence the processing of Abeta </plain></SENT>
</text></document>